AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,684,000 | +19.2% | 100,776 | +2.9% | 0.00% | 0.0% |
| Q1 2020 | $1,413,000 | -61.6% | 97,976 | -11.0% | 0.00% | -60.0% |
| Q4 2019 | $3,684,000 | +71.8% | 110,076 | +7.5% | 0.01% | +66.7% |
| Q3 2019 | $2,144,000 | +2.9% | 102,376 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $2,084,000 | -1.5% | 100,076 | +5.7% | 0.00% | 0.0% |
| Q1 2019 | $2,116,000 | -9.6% | 94,676 | -3.3% | 0.00% | -25.0% |
| Q4 2018 | $2,341,000 | -12.5% | 97,876 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $2,674,000 | +11.8% | 98,027 | +10.2% | 0.00% | 0.0% |
| Q2 2018 | $2,391,000 | -13.5% | 88,927 | +2.4% | 0.00% | 0.0% |
| Q1 2018 | $2,764,000 | +20.4% | 86,827 | +43.0% | 0.00% | +33.3% |
| Q4 2017 | $2,296,000 | +145.8% | 60,703 | +61.1% | 0.00% | +200.0% |
| Q3 2017 | $934,000 | +19.3% | 37,678 | -1.1% | 0.00% | 0.0% |
| Q2 2017 | $783,000 | +13.8% | 38,078 | +20.2% | 0.00% | 0.0% |
| Q1 2017 | $688,000 | +4.9% | 31,678 | -1.2% | 0.00% | 0.0% |
| Q4 2016 | $656,000 | +39.0% | 32,078 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $472,000 | +227.8% | 31,478 | +136.7% | 0.00% | – |
| Q2 2016 | $144,000 | -20.0% | 13,300 | 0.0% | 0.00% | – |
| Q1 2016 | $180,000 | -31.8% | 13,300 | -7.0% | 0.00% | -100.0% |
| Q4 2015 | $264,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |